NCT05211050View on ClinicalTrials.gov

Effect of Sumatriptan on Levcromakalim-Induced Symptoms in Individuals With Migraine

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 15, 2022

Primary Completion Date

November 5, 2023

Study Completion Date

November 5, 2023

Conditions
Migraine Without AuraHeadache
Interventions
DRUG

Levcromakalim

20 min infusion of 1 mg Levcromakalim followed by either sumatriptan or placebo.

DRUG

Sumatriptan

10 min infusion of 4 mg sumatriptan.

DRUG

Saline

10 min infusion of isotonic saline (placebo).

Trial Locations (1)

2600

Danish Headache Centre, Glostrup

All Listed Sponsors
lead

Danish Headache Center

OTHER